Dr. Cara Mathews, MD
Claim this profileWomen and Infants Hospital
Expert in Endometrial Cancer
Studies Ovarian Cancer
22 reported clinical trials
44 drugs studied
Area of expertise
1Endometrial Cancer
Global LeaderStage IV
Stage III
MMR negative
2Ovarian Cancer
Stage IV
Stage III
FRα positive
Affiliated Hospitals
Clinical Trials Cara Mathews, MD is currently running
Ipatasertib + Megestrol Acetate
for Endometrial Cancer
This trial is testing if combining two drugs, ipatasertib and megestrol acetate, is more effective than using megestrol acetate alone for treating women with endometrial cancer that has returned or spread. Ipatasertib blocks enzymes needed for cancer cell growth, while megestrol acetate reduces and blocks estrogen, which some cancer cells need to grow.
Recruiting1 award Phase 1 & 2
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
More about Cara Mathews, MD
Clinical Trial Related3 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Cara Mathews, MD has experience with
- Carboplatin
- Paclitaxel
- Pembrolizumab
- Bevacizumab
- Nivolumab
- Ipilimumab
Breakdown of trials Cara Mathews, MD has run
Endometrial Cancer
Ovarian Cancer
Endometrioid Carcinoma
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Cara Mathews, MD specialize in?
Cara Mathews, MD focuses on Endometrial Cancer and Ovarian Cancer. In particular, much of their work with Endometrial Cancer has involved Stage IV patients, or patients who are Stage III.
Is Cara Mathews, MD currently recruiting for clinical trials?
Yes, Cara Mathews, MD is currently recruiting for 8 clinical trials in Providence Rhode Island. If you're interested in participating, you should apply.
Are there any treatments that Cara Mathews, MD has studied deeply?
Yes, Cara Mathews, MD has studied treatments such as Carboplatin, Paclitaxel, Pembrolizumab.
What is the best way to schedule an appointment with Cara Mathews, MD?
Apply for one of the trials that Cara Mathews, MD is conducting.
What is the office address of Cara Mathews, MD?
The office of Cara Mathews, MD is located at: Women and Infants Hospital, Providence, Rhode Island 02905 United States. This is the address for their practice at the Women and Infants Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.